Estudio fase III de la seguridad y la eficacia de ciclopirox olamina crema en niños afectados de dermatomicosis

Gómez-Moyano, Elisabeth; Hiraldo Gamero, Alicia; Vera Casaño, Ángel; Crespo Erchiga, Vicente; González Enseñat, M. Antonia; Vicente Villa, M Asunción; Zsolt Fradera, Ilonka; Moreno Giménez, José Carlos.
Rev. iberoam. micol ; 32(3): 164-169, jul.-sept. 2015. tab, ilus
Artículo en Español | IBECS (España) | ID: ibc-142076

Documentos relacionados

  1. Combination oral antifungal therapy for paediatric fungal infection: An option to improve efficacy and overcome clinical resistance.
  2. Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis.
  3. Can we predict the influence of inflammation on voriconazole exposure? An overview.
  4. Osteomyelitis by Microsporum canis and Staphylococcus spp. in cat (Felis catus) - case report.
  5. Liposomal amphotericin B-the past.
  6. Population Pharmacokinetic Model and Optimal Sampling Strategies for Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
  7. A Regulatory Review Approach for Evaluation of Micafungin for Treatment of Neonatal Candidiasis.
  8. Posaconazole in paediatric malignancy and haematopoietic stem cell transplant: dosing to achieve therapeutic concentration.
  9. Clinical pharmacokinetics and outcomes of oral fluconazole therapy in dogs and cats with naturally occurring fungal disease.
  10. The efficacy of a novel topical spray composed of sodium benzoate, alcohol and botanical oils for the treatment of Malassezia dermatitis in dogs - a split body, randomised, blinded study.